< Back to Front Page
Text size
–
+
Breast cancer researchers look for clues to disease development
Researchers from Northeastern University and Massachusetts General Hospital are studying ways to predict which women with benign breast disease are at high risk of developing breast cancer.
Funded by a three-year, $1.3 million grant from the advocacy group Susan G. Komen for the Cure, Barry Karger of Northeastern and Dr. Dennis Sgroi of Mass. General hope to identify proteins that can be used to decide who would benefit from close monitoring or preventive measures.
This blogger might want to review your comment before posting it.
about white coat notes We post updates every weekday about the region's hospitals,
labs and medical schools – covering everything from the latest research findings to
what's on the minds of the innovative doctors, nurses and scientists who work here.
Send news items and tips to whitecoat@globe.com
Contributors
blogger
Elizabeth Cooney covers health for the Worcester Telegram & Gazette. She
previously reported on business and was an editor at the paper. Earlier in
her career, she edited medical books and journals at Little, Brown, and
worked for Boston magazine.Boston Globe Health and Science staff:
- Karen Weintraub, Deputy Health and Science Editor
- Gideon Gil, Health and Science Editor
- Ishani Ganguli, Short White Coat blogger
- Joshua U. Klein, M.D., Short White Coat blogger
I will dictate a lecture about BBD and cancer risk in next 7th National Mexican Congress on the Menopause.
IŽll focus my presentation in the development of novel markers (serological, histopathological, molecular, genetic) to identify BBD patients with high-risk.
How could I read more about your post?
Regards,
Dr. Luis Hernandez
Mexico City